
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Active composition
+1 more active ingredient
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
Medineuron PG 1500mcg/75mg Tablet SR is a sustained-release formulation combining Methylcobalamin 1500mcg and Pregabalin 75mg, designed for the management of neuropathic pain and related neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal metabolism. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its therapeutic effect by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain, seizures, and anxiety. The sustained-release formulation ensures a gradual and consistent release of both active ingredients, improving patient compliance and maintaining stable plasma concentrations over an extended period. Medineuron PG is indicated for conditions such as diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and neuropathic pain associated with spinal cord injury. It may also be used adjunctively in partial seizures. The combination therapy addresses both symptomatic relief and underlying nerve repair mechanisms, offering a comprehensive approach to neuropathic conditions. Patients should use this medication under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, and gastrointestinal disturbances.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Medineuron PG 1500mcg/75mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Medineuron PG 1500mcg/75mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Medineuron PG 1500mcg/75mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Medineuron PG 1500mcg/75mg Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Medineuron PG 1500mcg/75mg Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Medineuron PG 1500mcg/75mg Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Medineuron PG 1500mcg/75mg Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Medineuron PG 1500mcg/75mg Tablet SR

Methylcobalamin (1500mcg) + Pregabalin (75mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
Medineuron PG 1500mcg/75mg Tablet SR is a sustained-release formulation combining Methylcobalamin 1500mcg and Pregabalin 75mg, designed for the management of neuropathic pain and related neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal metabolism. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its therapeutic effect by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain, seizures, and anxiety. The sustained-release formulation ensures a gradual and consistent release of both active ingredients, improving patient compliance and maintaining stable plasma concentrations over an extended period. Medineuron PG is indicated for conditions such as diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and neuropathic pain associated with spinal cord injury. It may also be used adjunctively in partial seizures. The combination therapy addresses both symptomatic relief and underlying nerve repair mechanisms, offering a comprehensive approach to neuropathic conditions. Patients should use this medication under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, and gastrointestinal disturbances.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Medineuron PG 1500mcg/75mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Medineuron PG 1500mcg/75mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Medineuron PG 1500mcg/75mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Medineuron PG 1500mcg/75mg Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Medineuron PG 1500mcg/75mg Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Medineuron PG 1500mcg/75mg Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Medineuron PG 1500mcg/75mg Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Medineuron PG 1500mcg/75mg Tablet SR















